Keating Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Sell
1,931
-37
-2% -$17.8K 0.27% 35
2026
Q1
$967K Sell
1,968
-825
-30% -$448K 0.24% 35
2025
Q4
$1.62M Sell
2,793
-83
-3% -$46.9K 0.45% 32
2025
Q3
$1.39M Sell
2,876
-100
-3% -$46.5K 0.4% 34
2025
Q2
$1.21M Sell
2,976
-55
-2% -$23K 0.36% 34
2025
Q1
$1.51M Sell
3,031
-744
-20% -$403K 0.45% 32
2024
Q4
$1.96M Sell
3,775
-10
-0.3% -$5.5K 0.61% 30
2024
Q3
$2.34M Sell
3,785
-75
-2% -$44.4K 0.7% 29
2024
Q2
$2.13M Sell
3,860
-735
-16% -$421K 0.69% 28
2024
Q1
$2.67M Sell
4,595
-1,813
-28% -$1.02M 0.86% 27
2023
Q4
$3.4M Sell
6,408
-50
-0.8% -$24.2K 1.22% 27
2023
Q3
$3.27M Buy
6,458
+312
+5% +$166K 1.11% 27
2023
Q2
$3.21M Sell
6,146
-425
-6% -$229K 1.16% 27
2023
Q1
$3.79M Sell
6,571
-270
-4% -$152K 1.43% 25
2022
Q4
$3.77M Buy
6,841
+806
+13% +$427K 1.47% 26
2022
Q3
$3.06M Sell
6,035
-65
-1% -$36.4K 1.37% 26
2022
Q2
$3.31M Sell
6,100
-730
-11% -$402K 1.4% 25
2022
Q1
$4.03M Sell
6,830
-175
-2% -$101K 1.73% 22
2021
Q4
$4.67M Hold
7,005
2.07% 20
2021
Q3
$4M Hold
7,005
1.87% 22
2021
Q2
$3.53M Sell
7,005
-585
-8% -$276K 1.62% 24
2021
Q1
$3.46M Sell
7,590
-1,398
-16% -$667K 1.66% 25
2020
Q4
$4.19M Sell
8,988
-815
-8% -$382K 2.09% 20
2020
Q3
$4.33M Sell
9,803
-685
-7% -$283K 2.27% 17
2020
Q2
$3.8M Sell
10,488
-355
-3% -$119K 2.09% 18
2020
Q1
$3.08M Sell
10,843
-1,285
-11% -$405K 1.88% 22
2019
Q4
$3.94M Sell
12,128
-160
-1% -$48.5K 1.72% 24
2019
Q3
$3.58M Sell
12,288
-3,662
-23% -$1.05M 1.61% 27
2019
Q2
$4.68M Sell
15,950
-665
-4% -$183K 2.09% 23
2019
Q1
$4.55M Sell
16,615
-795
-5% -$198K 2.06% 23
2018
Q4
$3.9M Sell
17,410
-1,975
-10% -$463K 1.97% 21
2018
Q3
$4.73M Sell
19,385
-1,310
-6% -$301K 2.04% 19
2018
Q2
$4.29M Sell
20,695
-1,020
-5% -$217K 2.03% 22
2018
Q1
$4.48M Sell
21,715
-5,635
-21% -$1.18M 2.07% 20
2017
Q4
$5.19M Sell
27,350
-750
-3% -$144K 2.21% 20
2017
Q3
$5.32M Sell
28,100
-460
-2% -$83.3K 2.31% 21
2017
Q2
$4.98M Sell
28,560
-12,548
-31% -$2.11M 2.18% 23
2017
Q1
$6.31M Sell
41,108
-465
-1% -$71.1K 2.81% 15
2016
Q4
$5.87M Buy
41,573
+175
+0.4% +$25.8K 2.77% 15
2016
Q3
$6.58M Sell
41,398
-675
-2% -$104K 3.21% 10
2016
Q2
$6.22M Buy
42,073
+4,045
+11% +$597K 3.05% 13
2016
Q1
$5.38M Sell
38,028
-1,885
-5% -$253K 2.63% 17
2015
Q4
$5.66M Sell
39,913
-50
-0.1% -$6.67K 2.84% 15
2015
Q3
$4.89M Hold
39,963
2.63% 17
2015
Q2
$5.19M Sell
39,963
-725
-2% -$94.5K 2.64% 16
2015
Q1
$5.47M Hold
40,688
2.73% 15
2014
Q4
$5.1M Sell
40,688
-55
-0.1% -$6.69K 2.54% 16
2014
Q3
$4.96M Sell
40,743
-3,250
-7% -$395K 2.56% 19
2014
Q2
$5.19M Sell
43,993
-410
-0.9% -$48.3K 2.5% 20
2014
Q1
$5.34M Sell
44,403
-7,280
-14% -$866K 2.66% 16
2013
Q4
$5.75M Hold
51,683
2.94% 16
2013
Q3
$4.76M Sell
51,683
-170
-0.3% -$15.4K 2.66% 21
2013
Q2
$4.39M Buy
+51,853
New +$4.32M 2.47% 22

Other funds holding TMO

Keating Investment Counselors's TMO Position: Q2 2026 in Review

Keating Investment Counselors reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $17.8K and leaving 1,931 shares worth $968K. The position accounts for 0.27% of the portfolio, ranked #35.

Keating Investment Counselors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.58M in Q3 2016. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Keating Investment Counselors held 1,931 shares of Thermo Fisher Scientific worth $968K as of Q2 2026.
  • Keating Investment Counselors sold 37 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.8K.
  • Thermo Fisher Scientific made up 0.27% of Keating Investment Counselors's portfolio in Q2 2026, its #35 holding.
  • Keating Investment Counselors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Keating Investment Counselors's Thermo Fisher Scientific position peaked at $6.58M in Q3 2016.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.